Stay updated on AKST4290 with Aflibercept in nAMD Clinical Trial
Sign up to get notified when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.

Latest updates to the AKST4290 with Aflibercept in nAMD Clinical Trial page
- Check2 days agoChange DetectedThe Record History now includes a new revision entry v3.3.4 and removes v3.3.3, reflecting internal version tracking. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe history shows a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure item. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check51 days agoChange DetectedThe Record History shows a new revision entry (v3.3.2) and a deleted revision entry (v3.2.0).SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the government funding lapse notice and operating-status information; this banner was an administrative message rather than core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check73 days agoChange DetectedVersion 6 (submitted 2022-10-24) was added to the Record History, extending the list of revisions for this study. This update indicates ongoing documentation of changes to the study record.SummaryDifference0.1%

- Check102 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment; the old version tag (v3.1.0) was removed.SummaryDifference12%

Stay in the know with updates to AKST4290 with Aflibercept in nAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.